Utilizing Autologous Multipotent Mesenchymal Stromal Cells and -Tricalcium Phosphate Scaffold in Human Bone Defects: A Prospective, Controlled Feasibility Trial

Figure 5

(a) The progress of radiolucency over time. The radiolucency is expressed as the median percentage of the initial filling visible on the postoperative radiograph. The asterisk () indicates significant difference of the trial group in comparison to the control group. (b) The box plot graph showing the progress of radiolucency in the control group. (c) The box plot graph showing radiolucency in the trial group. The bottom and top of the box are the first and third quartiles, and the band inside the box is the median. The ends of the whiskers represent the minimum and maximum.

(a)

(b)

(c)